TAIGA Trademark

Trademark Overview

On Tuesday, June 23, 2020, a trademark application was filed for TAIGA with the United States Patent and Trademark Office. The USPTO has given the TAIGA trademark a serial number of 90016483. The federal status of this trademark filing is REGISTERED as of Tuesday, August 10, 2021. This trademark is owned by Taiga Biotechnologies, Inc.. The TAIGA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the biotechnology and pharmaceutical fields; testing, inspection, research, or development of biotechnology and pharmaceutical preparations for immunotherapies, cell-based therapeutics, and protein therapies
taiga

General Information

Serial Number90016483
Word MarkTAIGA
Filing DateTuesday, June 23, 2020
Status700 - REGISTERED
Status DateTuesday, August 10, 2021
Registration Number6444329
Registration DateTuesday, August 10, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements

Goods and ServicesResearch and development in the biotechnology and pharmaceutical fields; testing, inspection, research, or development of biotechnology and pharmaceutical preparations for immunotherapies, cell-based therapeutics, and protein therapies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 21, 2020
Primary Code042
First Use Anywhere DateMonday, July 31, 2006
First Use In Commerce DateSunday, July 1, 2007

Trademark Owner History

Party NameTaiga Biotechnologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAurora, CO 80045
Party NameTaiga Biotechnologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAurora, CO 80045
Party NameTaiga Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAurora, CO 80045

Trademark Events

Event DateEvent Description
Wednesday, June 7, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, June 7, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, June 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 10, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, July 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 1, 2020NON-FINAL ACTION E-MAILED
Thursday, October 1, 2020NON-FINAL ACTION WRITTEN
Thursday, September 24, 2020ASSIGNED TO EXAMINER
Tuesday, July 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2020NEW APPLICATION ENTERED

Related Keywords

taiga pharmaceutical research biotechnology development therapeutics based therapies cell protein inspection